期刊文献+

嗜酸粒细胞增多症诊断与治疗中国专家共识(2017年版) 被引量:88

Chinese expert consensus on the diagnosis and treatment of eosinophilia (2017)
原文传递
导出
摘要 为了进一步规范我国血液科医师对嗜酸粒细胞增多症患者的临床诊治,由中华医学会血液学分会白血病淋巴瘤学组牵头,在广泛征求国内专家意见基础上,最终达成了嗜酸粒细胞增多症的诊断程序、实验室检查、诊断标准和治疗原则等方面的共识。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2017年第7期561-565,共5页 Chinese Journal of Hematology
作者简介 通信作者:肖志坚,中国医学科学院血液学研究所、血液病医院,Email:zjxiao@hotmail.com 王建祥,中国医学科学院血液学研究所、血液病医院,Email:wangjx@ihcams.ac.cn
  • 相关文献

参考文献7

二级参考文献61

  • 1钱思轩,李建勇,沈云峰,蒋元强,陆化,吴汉新,徐卫,程蕴琳,盛瑞兰.CAG预激方案治疗老年人急性髓细胞白血病的临床观察[J].中华老年医学杂志,2007,26(4):248-250. 被引量:39
  • 2Hardy WR, Anderson RE. The hypereosinophilic syndromes. Ann Intern Med, 1968, 68 : 1220-1229.
  • 3Bain B, Pierre R, Imbert M, et al. Chronic eosinophilic leukaemia and the hypereosinophilic syndrome//Jaffe ES, Harris NL, Stein H, et al. World Health Organization of tumours : tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001 : 29-31.
  • 4Cools J, Deangelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1 L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med, 2003, 348 : 1201-1214.
  • 5Pongers-Willemse M J, Seriu T, Stolz F, et al. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TALl deletions as PCR targets. Leukemia, 1999,13:110-118.
  • 6Roche-Lestienne C, Lepers S, Soenen-Cornu V, et al. Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics. Leukemia, 2005, 19: 792-798.
  • 7Vandenberghe P, Wlodarska I, Michanx L, et al. Clinical and molecular features of FIP1 L1-PDFGRA ( + ) chronic eosinophilic leukemias. Leukemia, 2004, 18 : 734-742.
  • 8Klion AD, Noel P, Akin C, et al. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood, 2003, 101: 4660-4666.
  • 9James C, Ugo V, Le Couedic JP, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature, 2005, 434 :1144-1148.
  • 10Saharinen P, Vihinen M, Silvennoinen O. Autoinhibition of JAK2 tyrosine kinase is dependent on specific regions in its pseudokinase domain. Mol Biol Cell, 2003,14 : 1448-1459.

共引文献482

同被引文献324

引证文献88

二级引证文献228

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部